Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
6.59
+0.41 (6.63%)
At close: Nov 6, 2026, 4:00 PM EST
6.72
+0.13 (1.97%)
After-hours: Nov 6, 2026, 7:30 PM EST
Solid Biosciences Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, Solid Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $18.71. The average 1-year stock price forecast is 183.92% higher than the current stock price, while the lowest is $11 (+66.92%) and the highest is $26 (+294.54%).
Price Target: $18.71 (+183.92%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Solid Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 8 | 9 | 8 | 9 | 9 |
| Buy | 4 | 4 | 4 | 5 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 12 | 13 | 13 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $18 | Buy | Maintains | $18 | +173.14% | Nov 5, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates $20 | Buy | Reiterates | $20 | +203.49% | Nov 5, 2026 |
| Wedbush | Wedbush | Buy Maintains $15 | Buy | Maintains | $15 | +127.62% | Nov 5, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $18 | Buy | Maintains | $18 | +173.14% | Nov 5, 2026 |
| UBS | UBS | Buy Maintains $20 | Buy | Maintains | $20 | +203.49% | Nov 5, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
2.34M
EPS This Year
-1.70
from -1.99
EPS Next Year
-1.69
from -1.70
EPS and Forward PE are based on non-GAAP adjusted numbers.